Head Of Early Assets, Hematology

Zse68

Gaithersburg, MD, USA
Base: $270,221 - $405,332; bonus/equity: not speci...
Experience in biopharma industry
Strong matrix leadership skills
Commercial strategy for hematology assets
AstraZeneca aims to transform outcomes for patients with hematologic malignancies through innovative therapies

Job Summary

  • AstraZeneca aims to transform outcomes for patients with hematologic malignancies through innovative therapies.
  • The Head of Early Assets will shape the early hematology pipeline and ensure alignment with patient impact.
  • This role offers competitive compensation, including base salary, bonuses, and comprehensive benefits.

Matching Summary

AstraZeneca aims to transform outcomes for patients with hematologic malignancies through innovative therapies.

Salary

Base: $270,221 - $405,332; Bonus/Equity: Not specified; Benefits: Health benefits, retirement program

Skills & Requirements

Must-have

  • Experience in biopharma industry
  • Strong matrix leadership skills
  • Commercial strategy for hematology assets

Nice-to-have

  • Ability to influence without authority
  • Strong communication and storytelling skills
  • Experience engaging external stakeholders

Key Requirements

  • MD required; hematology-trained physician preferred
  • 10+ years in biopharma with hematology experience
  • Experience in early asset strategy

Work Rights

Not specified

Tailored Resume

Cover Letter